Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Human Immunodeficiency Virus-1 Drug Resistance Patterns Among Adult Patients Failing Second-Line Protease Inhibitor-Containing Regimens in Namibia, 2010-2015.

Sawadogo S, Shiningavamwe A, Roscoe C, Baughman AL, Negussie T, Mutandi G, Yang C, Hamunime N, Agolory S.

Open Forum Infect Dis. 2018 Jan 12;5(2):ofy014. doi: 10.1093/ofid/ofy014. eCollection 2018 Feb.

2.

Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia.

Hong SY, Jonas A, DeKlerk M, Shiningavamwe A, Desta T, Badi A, Morris L, Hunt GM, Ledwaba J, Sheehan HB, Lau K, Trotter A, Tang AM, Wanke C, Jordan MR.

J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):463-71. doi: 10.1097/QAI.0000000000000509.

3.

Limited utility of dried-blood- and plasma spot-based screening for antiretroviral treatment failure with Cobas Ampliprep/TaqMan HIV-1 version 2.0.

Sawadogo S, Shiningavamwe A, Chang J, Maher AD, Zhang G, Yang C, Gaeb E, Kaura H, Ellenberger D, Lowrance DW.

J Clin Microbiol. 2014 Nov;52(11):3878-83. doi: 10.1128/JCM.02063-14. Epub 2014 Aug 20.

4.

Population-based monitoring of HIV drug resistance in Namibia with early warning indicators.

Hong SY, Jonas A, Dumeni E, Badi A, Pereko D, Blom A, Muthiani VS, Shiningavamwe AN, Mukamba J, Andemichael G, Barbara R, Bennett DE, Jordan MR.

J Acquir Immune Defic Syndr. 2010 Dec;55(4):27-31. doi: 10.1097/QAI.0b013e3181f5376d.

5.

Heterologous expression of the benzoate para-hydroxylase encoding gene (CYP53B1) from Rhodotorula minuta by Yarrowia lipolytica.

Shiningavamwe A, Obiero G, Albertyn J, Nicaud JM, Smit M.

Appl Microbiol Biotechnol. 2006 Sep;72(2):323-9. Epub 2006 Jan 10.

PMID:
16402170

Supplemental Content

Loading ...
Support Center